EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
64.00
0.00 (0.00%)
At close: Feb 19, 2026
12.28% (1Y)
| Market Cap | 114.22M +22.6% |
| Revenue (ttm) | 9.37M +8.4% |
| Net Income | 2.38M +122.7% |
| EPS | 1.34 +123.3% |
| Shares Out | 1.78M |
| PE Ratio | 47.94 |
| Forward PE | n/a |
| Dividend | 1.83 (2.86%) |
| Ex-Dividend Date | n/a |
| Volume | 10 |
| Average Volume | 80 |
| Open | 60.00 |
| Previous Close | 64.00 |
| Day's Range | 60.00 - 64.00 |
| 52-Week Range | 56.00 - 65.50 |
| Beta | -0.09 |
| RSI | 53.04 |
| Earnings Date | Feb 10, 2026 |